Original language | English |
---|---|
Pages (from-to) | e542-e545 |
Journal | The Lancet Rheumatology |
Volume | 3 |
Issue number | 8 |
DOIs |
|
Publication status | Published - 1 Aug 2021 |
Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
Laura Boekel, Laura Y. Kummer, Koos P. J. van Dam, Femke Hooijberg, Zoé van Kempen, Erik H. Vogelzang, Luuk Wieske, Filip Eftimov, Ronald van Vollenhoven, Taco W. Kuijpers, S. Marieke van Ham, Sander W. Tas, Joep Killestein, Maarten Boers, Mike T. Nurmohamed, Theo Rispens, Gertjan Wolbink
- Neurology (AMC)
- AII - Inflammatory diseases (AMC)
- Amsterdam Neuroscience - Neuroinfection & -inflammation (AMC)
- EURO-NMD
- Clinical Immunology and Rheumatology (AMC)
- AMS - Musculoskeletal Health
- Landsteiner Laboratory (AMC)
- Paediatric Infectious Diseases / Rheumatology / Immunology (AMC)
- AR&D - Amsterdam Reproduction & Development
- Experimental Immunology (AMC)
- Rheumatology (VUmc)
- AII - Inflammatory diseases (VUmc)
- APH - Societal Participation & Health (VUmc)
- Neurology (VUmc)
- Amsterdam Neuroscience - Neuroinfection & -inflammation (VUmc)
- Medical Microbiology and Infection Prevention (VUmc)
- Epidemiology and Data Science (VUmc)
- APH - Methodology (VUmc)
- ACS - Atherosclerosis & ischemic syndromes (VUmc)
Research output: Contribution to journal › Comment/Letter to the editor › Academic
56
Citations
(Scopus)